PTGS2 and urinary bladder cancer: Our data reinforce the pivotal role of inflammation in tumor development as well as the relevance of chemopreventive strategies based on earlier COX-2 inhibition, which might be particularly relevant for high-risk individuals as well as for patients treated for a previous episode of bladder cancer and under high possibility of recurrence.